CELZ
NASDAQ · Biotechnology
Creative Medical Technology
$0.81
-0.39 (-32.48%)
Open$1.29
Previous Close$1.20
Day High$1.29
Day Low$0.79
52W High$6.25
52W Low$1.50
Volume—
Avg Volume100.1K
Market Cap4.44M
P/E Ratio—
EPS$-2.04
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,021.2% upside
Current
$0.81
$0.81
Target
$33.39
$33.39
$22.85
$33.39 avg
$43.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.2K | 22.8K | 749.0K |
| Net Income | -9,300,817 | -20,642,997 | -154,552 |
| Profit Margin | -99,916.8% | -94,921.0% | -20.6% |
| EBITDA | -9,338,523 | -21,878,167 | -155,667 |
| Free Cash Flow | — | — | -141,548 |
| Rev Growth | -59.5% | -59.5% | +1.8% |
| Debt/Equity | — | — | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.31 | +0.38% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $360.55 | +0.62% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.33 | -1.21% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $499.65 | +1.69% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $631.81 | -0.17% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.52 | +0.74% | 69.3 | 39.97B |